Olio Labs

Olio Labs

Private
San Francisco, CaliforniaHealthcare & Life Scienceshttps://oliolabs.co

Last Round

Series A

Mar 19, 2025

Total Funding Raised

$5M

Momentum Score

75 /100

Company Overview

Olio Labs is a biotechnology company founded in 2023 by Tom Roseberry and David Tingley. The company is developing a therapeutic design platform that utilizes artificial intelligence to create combination therapeutics. This approach considers the complex interactions of thousands of proteins in the body, aiming to produce more effective treatments with fewer side effects compared to traditional drugs that target only one or two proteins. Olio Labs' AI-powered Combination Design Engine (CoDE) platform leverages human medical records, biological data, and in-vivo screening to identify promising drug combinations. The company's initial focus is on developing treatments for obesity. Olio Labs participated in Y Combinator's Summer 2023 batch and has raised venture capital funding.

Sector

Healthcare & Life Sciences

Verticals

Drug Discovery, Biotechnology, Medical AI, ML Platforms, Healthcare Analytics

Business Model

B2B

Customer Profile

Services & Consulting

AI Layer

Non-AI

Keywords

digital product studiodigital product developmentoutsourced product developmentinnovation studiodigital product agencyproduct strategyproduct designproduct engineeringdev shopUX/UI designweb developmentmobile developmentventure studiodesign systemsprototyping

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

Olio Labs Comps

Public and private peers based on sector, stage, and business model.

CompanyStatusEst. ValuationRev Multiple
OpenAIPrivate$86.0B~40x
CoherePrivate$5.0B--
Competitor 1Public$XX.XBXXx
Competitor 2Public$XX.XBXXx

View Full Comps Set

Access detailed peer comparisons, multiples, and valuation benchmarks.

Olio Labs Funding Rounds

Historical fundraising activity

RoundDateAmount RaisedValuationInvestorsSources
Series AMar 19, 2025
SeedJul 1, 2023

Key People

Founding team and executive leadership

Tom Roseberry

Co-Founder CTO

Founding Team

Olio Labs Investors

Notable investors and investment history

InvestorRounds
Pioneer FundSeries A
Boom CapitalSeries A
ZAKA VCSeries A
Y CombinatorSeries A, Seed
Overwater VenturesSeries A
SciFoundersSeries A
Scrum VenturesSeries A

Market signals

Structured signals derived from secondary market and firmographic data.

  • Mar 19, 2025

    $5M Series A round completed.

Olio Labs Filings

SEC and related filings with document metadata.

TypedDateAmount OfferedAmount SoldFillingPagesDownload
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation

Olio Labs Filings

SEC and related filings with document metadata.

Frequently Asked Questions

Common questions about Olio Labs's valuation, stock price, and market status.

Firmographic Details

HeadquartersSan Francisco, California
Employee Range10
Year Founded2023
Last FundingMar 19, 2025

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.







Disclaimer All investments involve risk, including the risk of loss of principal. You should carefully consider your investment objectives, risks, transaction costs and other expenses before deciding to invest in options, swaps or other investments.This does not constitute an offer by Caplight Technologies, Inc. to sell, or a solicitation of an offer to buy, any securities and may not be used or relied upon in connection with any offer or sale of securities. An offer or solicitation can be made only through the delivery of final offering document(s) and purchase agreement(s), and will be subject to the terms and conditions and risks delivered in such documents. Any securities offered are offered through Caplight Markets LLC, member FINRA/SIPC.